CEL-SCI Newsroom

Express News | CEL-SCI Corp: On November 13, Patricia B Prichep Has Assumed the Duties of Chief Financial and Operations Officer

BreakingsNov 16 05:33

CEL-SCI, FDA Agree on Phase 3 Trial Design for Cancer Drug

Seeking AlphaNov 8 00:31

U.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025

BusinesswireNov 7 21:15

Express News | CEL-SCI Corp Files Prospectus Relates to Possible Resale, From Time to Time, by Selling Shareholder of up to 1 Mln Shares of Common Stock

BreakingsOct 26 05:22

CEL-SCI Announces The Potential Impact On The Clinical Development Of Its Immunotherapy Multikine Resulting From A Recent U.S. FDA Oncologic Drugs Advisory Committee Meeting; Multikine Has Shown Survival Benefit And Favorable Safety Profile In A...

BenzingaOct 22 21:26

FDA's Oncologic Drugs Advisory Committee Decision on Checkpoint Inhibitors Substantiates Potential of CEL-SCI's Multikine to Address Major Treatment Gap for PD-L1 Negative Cancer Patients

BusinesswireOct 22 21:15

CEL-SCI Selects Ergomed as CRO as It Gears Up for Confirmatory FDA Registration Study of Multikine in Head and Neck Cancer

BusinesswireOct 1 18:00

CEL-SCI's Multikine Increased 5-Year Survival Rate to 82.6% in Locally Advanced Resectable Head & Neck Cancer Patients Who Were Deemed to Be in the Treatment Group for Surgery and Radiation

BusinesswireSep 16 19:30

CEL-SCI to Present New Data for Multikine Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 Congress

BusinesswireSep 10 21:32

The UK's MHRA Grants CEL-SCI's Multikine A Product Specific Waiver For The Treatment Of Head And Neck Cancer In A Pediatric Population Of People Up To 18 Years Of Age

BenzingaSep 4 21:03

CEL-SCI Q3 2024 Adj EPS $(0.14) Misses $(0.11) Estimate

BenzingaAug 15 20:04

Express News | CEL-SCI Corporation Reports Third Quarter Fiscal 2024 Financial Results

BreakingsAug 15 20:00

CEL-SCI 3Q Loss/Shr 14c >CVM

Dow JonesAug 15 20:00

Cel-Sci: Fiscal Q3 Earnings Snapshot

Yahoo FinanceAug 15 17:09

CEL-SCI | 10-Q: Q3 2024 Earnings Report

SECAug 15 04:32 · Announcements

Express News | CEL-SCI Announces Closing of $10.8 Million Offering

BreakingsJul 30 04:05

Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session

BenzingaJul 27 01:25

CEL-SCI Shares Resume Trade

BenzingaJul 27 00:15

CEL-SCI Shares Halted On Circuit Breaker To The Downside, Stock Now Up 21.9%

BenzingaJul 26 23:59

CEL-SCI's Offering of 10.8M Shares or Pre-Funded Warrants Prices at $1 a Share >CVM

Dow JonesJul 26 23:53